MBX Biosciences Investigational Site

San Antonio, Texas 78231

0 studies enrolling now · 3 studies all time

What they study most

Hypoparathyroidism, Postbariatric Hypoglycemia

Studies at this site

• Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI) — Completed
• Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism — Completed
• Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism — Running, not enrolling